<DOC>
	<DOCNO>NCT00823420</DOCNO>
	<brief_summary>A single centre randomise control trial investigate influence novel prematuration system ( PMS ) use phosphodiesterase-3 inhibitor in-vitro maturation oocyte</brief_summary>
	<brief_title>Influence Prematuration Culture With Phosphodiesterase-3 Inhibitor ( PDE3-I ) Embryonic Aneuploidy Rate Developmental Potential</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Phosphodiesterase 3 Inhibitors</mesh_term>
	<criteria>healthy volunteer , either PCOS/PCOSlike ovary , normal ovary , undergo oocyte donation research AFC least 10 AMH : &gt; 5 Î¼g/L Female age &lt; 36 year major uterine ovarian abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>PCOS normal ovulatory patient</keyword>
	<keyword>aneuploidy</keyword>
	<keyword>in-vitro maturation oocyte</keyword>
</DOC>